NewsRx

Search our medical news database

Diet & Nutrition

Fast-food Mediterranean-type diet rich in PAF antagonist improved platelet response

Published in Obesity and Diabetes Week, June 19th, 2006

Fast-food Mediterranean-type diet rich in platelet activating factor antagonist improved platelet response of type 2 diabetics and healthy human.

"The aim of our work was to carry out a randomized clinical trial with a fast-food Mediterranean-type diet rich in platelet activating factor (PAF) antagonist to investigate the effect on type 2 diabetics and healthy human subject's platelet aggregation," scientists in Greece report.

H.C. Karantonis and colleagues working with the National and Kapodistrian University of Athens explained, "We extracted lipids from fast-food Mediterranean-type foodstuffs, and tested them in vitro for their ability to inhibit...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook